Repligen | RGEN - Interest Income


Repligen reported $7.31M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Agilent USD 15M 2M Dec/2025
Align Technology USD 4.62M 1.37M Dec/2025
Bio Techne USD 897K 74K Dec/2025
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Bruker USD 4.4M 1.5M Sep/2025
Charles River Laboratories USD -0.3 1.02M Mar/2026
Danaher USD 27M 14M Mar/2026
Dentsply International USD 4M 1000K Mar/2025
General Electric Aerospace USD 450M 288M Dec/2025
Henry Schein USD 0.92 9M Mar/2026
Illumina USD 0.87 10M Mar/2026
IQVIA Holdings USD 10M 1000K Mar/2026
Myriad Genetics USD 300K 0 Mar/2025
Pfizer USD 115M 51M Mar/2026
Repligen USD 7.31M 979K Mar/2025
Revvity USD 5.75M 5.75M Dec/2025
Standard Biotools USD 2.14M 321K Sep/2025
Thermo Fisher Scientific USD 258M 258M Dec/2025
Waters USD 5.67M 5.67M Dec/2025
West Pharmaceutical Services USD 5.1M 400K Dec/2025